Home
About
Overview
Sharing Data
ORCID
Help
History (19)
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part I: Event Rates and Clinical Outcome.
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling.
Synthesis of nerve growth factor by L and 3T3 cells in culture.
Impact of Pial Collaterals on Infarct Growth Rate in Experimental Acute Ischemic Stroke.
Mitigation of Cerebral Infarct Growth in Acute Ischemic Stroke Using a Novel Blood Substitute
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mitigation of Cerebral Infarct Growth in Acute Ischemic Stroke Using a Novel Blood Substitute
Overview
sponsor award id
R01NS138410
Biography
contributor
Principal Investigator
Time
start date
2024-08-01
end date
2029-07-31